Real-time enrollment status for this i cannot determine the primary medical condition from the provided information. the study title mentions car-t cell therapy targeting cadherin 17, but the conditions section only lists the treatment itself rather than the disease being treated. the brief summary appears to be incomplete (showing only a localhost url). without additional context about what cancer or condition this car-t therapy is intended to treat, i cannot provide the patient-facing medical condition. clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 2:02 PM UTC
| NCT Number | NCT06055439 |
| Recruiting Status | Recruiting |
| Condition | I cannot determine the primary medical condition from the provided information. The study title mentions CAR-T cell therapy targeting Cadherin 17, but the conditions section only lists the treatment itself rather than the disease being treated. The brief summary appears to be incomplete (showing only a localhost URL). Without additional context about what cancer or condition this CAR-T therapy is intended to treat, I cannot provide the patient-facing medical condition. |
| Phase | Clinical Trial |
| Target Enrollment | 135 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Chimeric Therapeutics |
| Last Updated on CT.gov | January 29, 2026 (Jan 29, 2026) |
As of March 2, 2026: Clinical trial NCT06055439 is currently recruiting participants. This clinical trial study for i cannot determine the primary medical condition from the provided information. the study title mentions car-t cell therapy targeting cadherin 17, but the conditions section only lists the treatment itself rather than the disease being treated. the brief summary appears to be incomplete (showing only a localhost url). without additional context about what cancer or condition this car-t therapy is intended to treat, i cannot provide the patient-facing medical condition. is actively seeking new participants at 4 locations across the United States. The study is sponsored by Chimeric Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06055439 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06055439 was last updated Jan 29, 2026 (January 29, 2026). HelloStudys verifies this status automatically.